We also found this therapy significantly increased GC-induced apoptosis of tumor cells and splenocytes in tumor-bearing mice (Fig. 3d, e), while Akt inhibitor IV or DEX alone did not achieve these results. The gene discussed is AKT1; the disease is neoplasm.